ADIM
CMD

Alpha DNA Investment Management’s Cantel Medical Corporation CMD Stock Holding History

Alpha DNA Investment Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22
Closed -$1K – 748
2021
Q1 		$1K Buy
+22
New +$1.72K ﹤0.01% 674

Alpha DNA Investment Management's CMD Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 22 shares — an estimated $1K sold.

Alpha DNA Investment Management first reported a position in CMD in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 22 Cantel Medical Corporation shares in Q2 2021, an estimated $1K.
  • Alpha DNA Investment Management first reported a position in Cantel Medical Corporation in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Cantel Medical Corporation position peaked at $1K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.